Prabha Parameswaran - 29 Aug 2022 Form 4 Insider Report for COLGATE PALMOLIVE CO (CL)

Role
Grp Pres, Growth & Strategy
Signature
/s/ Kristine Hutchinson, Attorney-in-Fact
Issuer symbol
CL
Transactions as of
29 Aug 2022
Net transactions value
-$283,259
Form type
4
Filing time
31 Aug 2022, 16:16:34 UTC
Previous filing
22 Feb 2022
Next filing
13 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CL Common Stock Options Exercise $3,560,306 +48,778 +719% $72.99 55,565 29 Aug 2022 Direct F1
transaction CL Common Stock Sale $3,843,565 -48,778 -88% $78.80 6,787 29 Aug 2022 Direct F2, F3
holding CL Common Stock 4,509 29 Aug 2022 By Issuer's 401(k) Plan Trustee
holding CL Common Stock 20,570 29 Aug 2022 By Trust F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CL Stock Option (Right to Buy) Options Exercise $0 -48,778 -100% $0.000000* 0 29 Aug 2022 Common Stock 48,778 $72.99 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of stock options awarded under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $78.45 to $79.06, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 This amount includes 7,407 shares that were previously reported as directly beneficially owned.
F5 Option became exercisable in one-third increments beginning on the first anniversary of the September 8, 2016 grant date.